Suraj K. George

641 total citations
23 papers, 518 citations indexed

About

Suraj K. George is a scholar working on Molecular Biology, Pathology and Forensic Medicine and Immunology. According to data from OpenAlex, Suraj K. George has authored 23 papers receiving a total of 518 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Biology, 5 papers in Pathology and Forensic Medicine and 5 papers in Immunology. Recurrent topics in Suraj K. George's work include Immune Cell Function and Interaction (4 papers), Nanoparticle-Based Drug Delivery (4 papers) and Chronic Lymphocytic Leukemia Research (3 papers). Suraj K. George is often cited by papers focused on Immune Cell Function and Interaction (4 papers), Nanoparticle-Based Drug Delivery (4 papers) and Chronic Lymphocytic Leukemia Research (3 papers). Suraj K. George collaborates with scholars based in United States, India and China. Suraj K. George's co-authors include T.T. Sreelekha, Manu M. Joseph, S.R. Aravind, S. Mini, Sheeja Varghese, K. Raveendran Pillai, Hesham M. Amin, Ping Shi, Deeksha Vishwamitra and Ahmed O. Kaseb and has published in prestigious journals such as Blood, Carbohydrate Polymers and Cancer Letters.

In The Last Decade

Suraj K. George

23 papers receiving 512 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Suraj K. George United States 14 204 97 90 83 72 23 518
Noureldien H. E. Darwish United States 14 246 1.2× 109 1.1× 77 0.9× 69 0.8× 52 0.7× 36 621
Ailing Wei China 9 201 1.0× 108 1.1× 90 1.0× 60 0.7× 32 0.4× 22 658
Sau Har Lee Malaysia 13 314 1.5× 123 1.3× 43 0.5× 56 0.7× 74 1.0× 34 731
Xiaoxia Che China 16 315 1.5× 70 0.7× 92 1.0× 45 0.5× 32 0.4× 36 693
Bing Ji China 16 450 2.2× 110 1.1× 93 1.0× 95 1.1× 45 0.6× 29 802
Ana Carolina Martínez‐Torres Mexico 15 183 0.9× 110 1.1× 60 0.7× 67 0.8× 51 0.7× 29 540
Sameera Nallanthighal United States 9 290 1.4× 221 2.3× 56 0.6× 93 1.1× 37 0.5× 13 705
Sung Yong Choi South Korea 13 132 0.6× 56 0.6× 34 0.4× 46 0.6× 32 0.4× 29 485

Countries citing papers authored by Suraj K. George

Since Specialization
Citations

This map shows the geographic impact of Suraj K. George's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Suraj K. George with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Suraj K. George more than expected).

Fields of papers citing papers by Suraj K. George

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Suraj K. George. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Suraj K. George. The network helps show where Suraj K. George may publish in the future.

Co-authorship network of co-authors of Suraj K. George

This figure shows the co-authorship network connecting the top 25 collaborators of Suraj K. George. A scholar is included among the top collaborators of Suraj K. George based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Suraj K. George. Suraj K. George is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Issa, Ghayas C., David Lavie, Amanda Przespolewski, et al.. (2022). Phase 1b Trial of Anti-Immunoglobulin-like Transcript 3 Monoclonal Antibody MK-0482 Monotherapy in Relapsed/Refractory Acute Myeloid Leukemia and Chronic Myelomonocytic Leukemia. Blood. 140(Supplement 1). 11759–11760. 1 indexed citations
2.
George, Bhawana, et al.. (2022). Enhancing Antigen Retrieval to Unmask Signaling Phosphoproteins in Formalin-fixed Archival Tissues. Applied immunohistochemistry & molecular morphology. 30(5). 333–339. 1 indexed citations
3.
George, Bhawana, Suraj K. George, Wenyu Shi, et al.. (2019). Dual inhibition of IGF-IR and ALK as an effective strategy to eradicate NPM-ALK+ T-cell lymphoma. Journal of Hematology & Oncology. 12(1). 80–80. 9 indexed citations
4.
Mitchell, Jennifer, Peggy T. Tinkey, Rony Avritscher, et al.. (2016). Validation of a Preclinical Model of Diethylnitrosamine-Induced Hepatic Neoplasia in Yucatan Miniature Pigs. Oncology. 91(2). 90–100. 21 indexed citations
6.
Vishwamitra, Deeksha, Suraj K. George, Ping Shi, Ahmed O. Kaseb, & Hesham M. Amin. (2016). Type I insulin-like growth factor receptor signaling in hematological malignancies. Oncotarget. 8(1). 1814–1844. 37 indexed citations
7.
Joseph, Manu M., S.R. Aravind, Suraj K. George, et al.. (2015). Anticancer activity of galactoxyloglucan polysaccharide-conjugated doxorubicin nanoparticles: Mechanistic insights and interactome analysis. European Journal of Pharmaceutics and Biopharmaceutics. 93. 183–195. 23 indexed citations
8.
Xu, Yinyin, Bingda Chen, Suraj K. George, & Beizhong Liu. (2015). Downregulation of MicroRNA-152 contributes to high expression of DKK1 in multiple myeloma. RNA Biology. 12(12). 1314–1322. 24 indexed citations
9.
Xu, Min, Aihua Gong, Hongqiong Yang, et al.. (2015). Sonic hedgehog-glioma associated oncogene homolog 1 signaling enhances drug resistance in CD44+/Musashi-1+ gastric cancer stem cells. Cancer Letters. 369(1). 124–133. 58 indexed citations
10.
Joseph, Manu M., Suraj K. George, & T.T. Sreelekha. (2015). Bridging 'Green' with Nanoparticles: Biosynthesis Approaches for Cancer Management and Targeting of Cancer Stem Cells. Current Nanoscience. 12(1). 47–62. 8 indexed citations
11.
Joseph, Manu M., S.R. Aravind, Suraj K. George, et al.. (2014). Antitumor activity of galactoxyloglucan-gold nanoparticles against murine ascites and solid carcinoma. Colloids and Surfaces B Biointerfaces. 116. 219–227. 25 indexed citations
12.
Joseph, Manu M., S.R. Aravind, Suraj K. George, et al.. (2014). Galactoxyloglucan-Modified Nanocarriers of Doxorubicin for Improved Tumor-Targeted Drug Delivery with Minimal Toxicity. Journal of Biomedical Nanotechnology. 10(11). 3253–3268. 52 indexed citations
13.
Joseph, Manu M., et al.. (2014). Co-Encapsulation of Doxorubicin With Galactoxyloglucan Nanoparticles for Intracellular Tumor-Targeted Delivery in Murine Ascites and Solid Tumors. Translational Oncology. 7(5). 525–536. 24 indexed citations
14.
Aravind, S.R., Manu M. Joseph, Suraj K. George, et al.. (2014). TRAIL-based tumor sensitizing galactoxyloglucan, a novel entity for targeting apoptotic machinery. The International Journal of Biochemistry & Cell Biology. 59. 153–166. 23 indexed citations
15.
Huang, Peng, et al.. (2014). Nucleus pulposus cells derived IGF-1 and MCP-1 enhance osteoclastogenesis and vertebrae disruption in lumbar disc herniation.. PubMed. 7(12). 8520–31. 19 indexed citations
16.
Zhang, Qiguo, Jing Wang, Jian Ouyang, et al.. (2014). Six cases of aggressive natural killer-cell leukemia in a Chinese population.. PubMed. 7(6). 3423–31. 14 indexed citations
17.
18.
George, Suraj K., Steven S. Shen, Weiguo Jian, et al.. (2013). Chemoprevention of BBN-Induced Bladder Carcinogenesis by the Selective Estrogen Receptor Modulator Tamoxifen. Translational Oncology. 6(3). 244–255. 38 indexed citations
19.
Joseph, Manu M., S.R. Aravind, Suraj K. George, Sheeja Varghese, & T.T. Sreelekha. (2013). A galactomannan polysaccharide from Punica granatum imparts in vitro and in vivo anticancer activity. Carbohydrate Polymers. 98(2). 1466–1475. 85 indexed citations
20.
George, Suraj K., et al.. (2013). Chemopreventive Efficacy of Aegle marmelos on Murine Transplantable Tumors. Integrative Cancer Therapies. 13(1). 68–78. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026